New findings show that the stage of normal cell development at which B cells transform into leukemic cells affects treatment outcomes for paediatric...
Vous n'êtes pas connecté
Chimeric antigen receptor (CAR) T–cell immunotherapy re-engineers a patient’s immune cells to target cancer cells. While successful in some types of leukaemia, the approach has yet to realise its potential against paediatric solid tumours. Scientists at St. Jude Children’s Research Hospital have identified a way to improve CAR T–cell homing – a T cell’s ability [...]
New findings show that the stage of normal cell development at which B cells transform into leukemic cells affects treatment outcomes for paediatric...
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...
A new comprehensive review reveals that harnessing natural killer (NK) cells by blocking their “off-switches” could significantly enhance cancer...
A new comprehensive review reveals that harnessing natural killer (NK) cells by blocking their “off-switches” could significantly enhance cancer...
Overview of Autologous Cell Therapy Product Market Global Cell Therapy Market is valued at USD 10.1 Billion in 2025 and is projected to attain a value...
Overview of Autologous Cell Therapy Product Market Global Cell Therapy Market is valued at USD 10.1 Billion in 2025 and is projected to attain a value...
At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the immune system, and immune...
A new research paper was published in Volume 16 of Oncotarget on July 9, 2025, titled "A novel anti-human CD25 mAb with preferential reactivity to...